This message was posted by a user wishing to remain anonymous
Hello,
A company is developing a SaMD for evaluation of ECG data. There are several questions coming up about the ECG data used to evaluate the effectiveness of the software. Can anyone help with the below questions? The questions are geared for an FDA submission.
1. Do cardiologists need to annotate the ECG data or can it be any trained personnel?
2. How many blinded cardiologist/trained personnel are required to annotate the data?
3. Are there requirements for where this data comes from? (I.e. US vs other jurisdictions)?